Gunnar Einvik1, Helge Røsjø1, Anna Randby1, Silje K Namtvedt1, Harald Hrubos-Strøm2, Jon Brynildsen1, Virend K Somers3, Torbjørn Omland1. 1. Department of Cardiology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway and Center for Heart Failure Research and K.G. Jebsen Cardiac Research Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 2. Division of Surgery, Department of Otorhinolaryngology, Akershus University Hospital, Lørenskog, Norway and Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 3. Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Foundation for Medical Education and Research, Rochester, MN.
Abstract
OBJECTIVES: Previous community-based studies have failed to demonstrate an independent association between OSA and circulating cardiac troponin concentrations, a marker of myocardial injury. However, these studies have used troponin assays with modest analytic sensitivity to detect low-level, chronic increments in troponin levels. Using a highly sensitive troponin I (hs-TnI) assay, we tested the hypothesis that the severity of OSA is associated with myocardial injury independently of comorbidities. DESIGN: Cross-sectional study. SETTING: Community-based. PARTICIPANTS: 514 subjects (54% men, age 48 ± 11 y [mean ± SD]). INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS: hs-TnI concentrations were measured in fasting morning blood samples and 318 participants (62%) had hs-TnI concentration above the limit of detection ([LoD] 1.2 ng/L). The severity of OSA, expressed as the apnea-hypopnea index (AHI) and nocturnal hypoxemia, was assessed by in-hospital polysomnography. After adjustment for age, gender, estimated creatinine clearance, history of coronary artery disease and hypertension, smoking, diabetes mellitus, systolic blood pressure, heart rate, body mass index, left ventricular hypertrophy, and cholesterol ratio in multivariate linear regression models, higher AHI (standardized β = 0.12, P = 0.006), lower mean SpO2 (β = -0.13, P = 0.012) and higher percentage of total sleep time with SpO2 < 90% (β = 0.12, P = 0.011) were all associated with higher hs-TnI levels in separate models. Additional analyses with hs-TnI categorized in tertiles or using a different strategy for persons with hs-TnI levels below the LoD did not change the results. CONCLUSION: Increased obstructive sleep apnea (OSA) severity is independently associated with higher concentrations of hs-TnI, suggesting that frequent apneas or hypoxemia in OSA may cause low-grade myocardial injury.
OBJECTIVES: Previous community-based studies have failed to demonstrate an independent association between OSA and circulating cardiac troponin concentrations, a marker of myocardial injury. However, these studies have used troponin assays with modest analytic sensitivity to detect low-level, chronic increments in troponin levels. Using a highly sensitive troponin I (hs-TnI) assay, we tested the hypothesis that the severity of OSA is associated with myocardial injury independently of comorbidities. DESIGN: Cross-sectional study. SETTING: Community-based. PARTICIPANTS: 514 subjects (54% men, age 48 ± 11 y [mean ± SD]). INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS:hs-TnI concentrations were measured in fasting morning blood samples and 318 participants (62%) had hs-TnI concentration above the limit of detection ([LoD] 1.2 ng/L). The severity of OSA, expressed as the apnea-hypopnea index (AHI) and nocturnal hypoxemia, was assessed by in-hospital polysomnography. After adjustment for age, gender, estimated creatinine clearance, history of coronary artery disease and hypertension, smoking, diabetes mellitus, systolic blood pressure, heart rate, body mass index, left ventricular hypertrophy, and cholesterol ratio in multivariate linear regression models, higher AHI (standardized β = 0.12, P = 0.006), lower mean SpO2 (β = -0.13, P = 0.012) and higher percentage of total sleep time with SpO2 < 90% (β = 0.12, P = 0.011) were all associated with higher hs-TnI levels in separate models. Additional analyses with hs-TnI categorized in tertiles or using a different strategy for persons with hs-TnI levels below the LoD did not change the results. CONCLUSION: Increased obstructive sleep apnea (OSA) severity is independently associated with higher concentrations of hs-TnI, suggesting that frequent apneas or hypoxemia in OSA may cause low-grade myocardial injury.
Authors: Aslan T Turer; Tayo A Addo; Justin L Martin; Marc S Sabatine; Gregory D Lewis; Robert E Gerszten; Ellen C Keeley; Joaquin E Cigarroa; Richard A Lange; L David Hillis; James A de Lemos Journal: J Am Coll Cardiol Date: 2011-06-14 Impact factor: 24.094
Authors: Allan S Jaffe; Vlad C Vasile; Margherita Milone; Amy K Saenger; Kalen N Olson; Fred S Apple Journal: J Am Coll Cardiol Date: 2011-09-29 Impact factor: 24.094
Authors: Harald Hrubos-Strøm; Anna Randby; Silje K Namtvedt; Håvard A Kristiansen; Gunnar Einvik; Jūratėšaltytė Benth; Virend K Somers; Inger H Nordhus; Michael B Russell; Toril Dammen; Torbjørn Omland; Kari J Kværner Journal: J Sleep Res Date: 2011-03 Impact factor: 3.981
Authors: J-P Baguet; G Barone-Rochette; P Lévy; E Vautrin; H Pierre; O Ormezzano; J-L Pépin Journal: Eur Respir J Date: 2010-06-18 Impact factor: 16.671
Authors: Gabriela Querejeta Roca; Susan Redline; Brian Claggett; Natalie Bello; Christie M Ballantyne; Scott D Solomon; Amil M Shah Journal: Circulation Date: 2015-08-27 Impact factor: 29.690
Authors: M Melanie Lyons; Nitin Y Bhatt; Elizabeth Kneeland-Szanto; Brendan T Keenan; Joanne Pechar; Branden Stearns; Nabil M Elkassabany; Stavros G Memtsoudis; Allan I Pack; Indira Gurubhagavatula Journal: Biomark Med Date: 2016 Impact factor: 2.851
Authors: Camila M de Melo; Luigi Taranto-Montemurro; James P Butler; David P White; Stephen H Loring; Ali Azarbarzin; Melania Marques; Philip J Berger; Andrew Wellman; Scott A Sands Journal: Sleep Date: 2017-10-01 Impact factor: 5.849
Authors: Macy M S Lui; H F Tse; Judith C W Mak; David C L Lam; Carmen W S Chan; Peony W C Chong; Mary S M Ip Journal: J Clin Sleep Med Date: 2018-11-15 Impact factor: 4.062
Authors: Neomi A Shah; Michelle Reid; Jorge R Kizer; Ravi K Sharma; Ravi V Shah; Vaishnavi Kundel; Bharath Ambale-Venkatesh; Zahi A Fayad; Steven J Shea; Robert C Kaplan; Joao A C Lima; Susan Redline Journal: J Clin Sleep Med Date: 2020-06-15 Impact factor: 4.324